Stock Analysis on Net
Stock Analysis on Net

Abiomed Inc. (NASDAQ:ABMD)

This company has been moved to the archive! The financial data has not been updated since November 3, 2022.

DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
Quarterly Data

Microsoft Excel

Decomposing ROE involves expressing net income divided by shareholders’ equity as the product of component ratios.

Two-Component Disaggregation of ROE

Abiomed Inc., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = ROA × Financial Leverage
Sep 30, 2022 17.32% = 15.72% × 1.10
Jun 30, 2022 14.16% = 12.77% × 1.11
Mar 31, 2022 9.08% = 8.16% × 1.11
Dec 31, 2021 9.28% = 8.35% × 1.11
Sep 30, 2021 10.77% = 9.75% × 1.11
Jun 30, 2021 11.81% = 10.59% × 1.12
Mar 31, 2021 16.96% = 15.09% × 1.12
Dec 31, 2020 15.89% = 14.03% × 1.13
Sep 30, 2020 17.58% = 15.65% × 1.12
Jun 30, 2020 14.40% = 12.70% × 1.13
Mar 31, 2020 19.05% = 16.69% × 1.14
Dec 31, 2019 23.42% = 20.49% × 1.14
Sep 30, 2019 22.27% = 19.64% × 1.13
Jun 30, 2019 25.72% = 22.92% × 1.12
Mar 31, 2019 27.65% = 24.57% × 1.13
Dec 31, 2018 26.06% = 23.18% × 1.12
Sep 30, 2018 24.02% = 21.47% × 1.12
Jun 30, 2018 22.79% = 20.30% × 1.12
Mar 31, 2018 16.27% = 14.26% × 1.14
Dec 31, 2017 14.26% = 12.54% × 1.14
Sep 30, 2017 15.24% = 13.27% × 1.15
Jun 30, 2017 13.51% = 11.74% × 1.15
Mar 31, 2017 11.53% = 9.47% × 1.22
Dec 31, 2016 — = — × 1.20
Sep 30, 2016 — = — × 1.19
Jun 30, 2016 — = — × 1.14

Based on: 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-K (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-K (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-K (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-K (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-K (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-K (reporting date: 2017-03-31), 10-Q (reporting date: 2016-12-31), 10-Q (reporting date: 2016-09-30), 10-Q (reporting date: 2016-06-30).

The primary reason for the increase in return on equity ratio (ROE) over Q2 2023 is the increase in profitability measured by return on assets ratio (ROA).

Three-Component Disaggregation of ROE

Abiomed Inc., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = Net Profit Margin × Asset Turnover × Financial Leverage
Sep 30, 2022 17.32% = 24.84% × 0.63 × 1.10
Jun 30, 2022 14.16% = 20.60% × 0.62 × 1.11
Mar 31, 2022 9.08% = 13.23% × 0.62 × 1.11
Dec 31, 2021 9.28% = 13.26% × 0.63 × 1.11
Sep 30, 2021 10.77% = 15.32% × 0.64 × 1.11
Jun 30, 2021 11.81% = 16.51% × 0.64 × 1.12
Mar 31, 2021 16.96% = 26.61% × 0.57 × 1.12
Dec 31, 2020 15.89% = 24.66% × 0.57 × 1.13
Sep 30, 2020 17.58% = 25.88% × 0.60 × 1.12
Jun 30, 2020 14.40% = 19.88% × 0.64 × 1.13
Mar 31, 2020 19.05% = 24.14% × 0.69 × 1.14
Dec 31, 2019 23.42% = 29.14% × 0.70 × 1.14
Sep 30, 2019 22.27% = 26.92% × 0.73 × 1.13
Jun 30, 2019 25.72% = 32.35% × 0.71 × 1.12
Mar 31, 2019 27.65% = 33.66% × 0.73 × 1.13
Dec 31, 2018 26.06% = 30.12% × 0.77 × 1.12
Sep 30, 2018 24.02% = 27.60% × 0.78 × 1.12
Jun 30, 2018 22.79% = 25.71% × 0.79 × 1.12
Mar 31, 2018 16.27% = 18.89% × 0.76 × 1.14
Dec 31, 2017 14.26% = 16.59% × 0.76 × 1.14
Sep 30, 2017 15.24% = 18.27% × 0.73 × 1.15
Jun 30, 2017 13.51% = 16.13% × 0.73 × 1.15
Mar 31, 2017 11.53% = 11.70% × 0.81 × 1.22
Dec 31, 2016 — = — × — × 1.20
Sep 30, 2016 — = — × — × 1.19
Jun 30, 2016 — = — × — × 1.14

Based on: 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-K (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-K (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-K (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-K (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-K (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-K (reporting date: 2017-03-31), 10-Q (reporting date: 2016-12-31), 10-Q (reporting date: 2016-09-30), 10-Q (reporting date: 2016-06-30).

The primary reason for the increase in return on equity ratio (ROE) over Q2 2023 is the increase in profitability measured by net profit margin ratio.

Two-Component Disaggregation of ROA

Abiomed Inc., decomposition of ROA (quarterly data)

Microsoft Excel
ROA = Net Profit Margin × Asset Turnover
Sep 30, 2022 15.72% = 24.84% × 0.63
Jun 30, 2022 12.77% = 20.60% × 0.62
Mar 31, 2022 8.16% = 13.23% × 0.62
Dec 31, 2021 8.35% = 13.26% × 0.63
Sep 30, 2021 9.75% = 15.32% × 0.64
Jun 30, 2021 10.59% = 16.51% × 0.64
Mar 31, 2021 15.09% = 26.61% × 0.57
Dec 31, 2020 14.03% = 24.66% × 0.57
Sep 30, 2020 15.65% = 25.88% × 0.60
Jun 30, 2020 12.70% = 19.88% × 0.64
Mar 31, 2020 16.69% = 24.14% × 0.69
Dec 31, 2019 20.49% = 29.14% × 0.70
Sep 30, 2019 19.64% = 26.92% × 0.73
Jun 30, 2019 22.92% = 32.35% × 0.71
Mar 31, 2019 24.57% = 33.66% × 0.73
Dec 31, 2018 23.18% = 30.12% × 0.77
Sep 30, 2018 21.47% = 27.60% × 0.78
Jun 30, 2018 20.30% = 25.71% × 0.79
Mar 31, 2018 14.26% = 18.89% × 0.76
Dec 31, 2017 12.54% = 16.59% × 0.76
Sep 30, 2017 13.27% = 18.27% × 0.73
Jun 30, 2017 11.74% = 16.13% × 0.73
Mar 31, 2017 9.47% = 11.70% × 0.81
Dec 31, 2016 — = — × —
Sep 30, 2016 — = — × —
Jun 30, 2016 — = — × —

Based on: 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-K (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-K (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-K (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-K (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-K (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-K (reporting date: 2017-03-31), 10-Q (reporting date: 2016-12-31), 10-Q (reporting date: 2016-09-30), 10-Q (reporting date: 2016-06-30).

The primary reason for the increase in return on assets ratio (ROA) over Q2 2023 is the increase in profitability measured by net profit margin ratio.